baber/WOPTO huggingface dataset:
Patent NZ-293910-A (NZ)
Title: Peptides useful in immunoregulation of antibodies to human myelin basic protein, pharmaceutical compositions and method of treatment
Inventor: WARREN KENNETH G
IPC: A61K38/08
Filed: 1995-10-20
Abstract: Human myelin basic protein (h-MBP) has a molecular weight of 18.5 KD and contains 170 amino acid residues. Synthetic peptides ranging in length from about 8 to 25 residues and covering the entire length of the protein have been produced. Antibodies to h-MBP (anti-MBP) were found to be neutralized by the synthetic peptides, in vitro, which span the h-MBP from about amino acid residue 61 to about amino acid residue 106. The peptides, which cover both the amino (about residues 1 to 63) and carboxy (about residues 117 to 162) terminals of h-MBP did not neutralize purified anti-MBP. Intrathecal administration of peptide MBP75-95, either as a single dose, or as repeated injections for periods up to 10 weeks, produced complete binding-neutralization of free (F) anti-MBP with no change in bound (B) levels. A control peptide MBP35-58 had no effect on F or B anti-MBP levels. Intravenous administration of MBP75-95 resulted in significant decline of F and B CSF anti-MBP levels over a period of one month. Administration of MBP synthetic peptides to MS patients either intrathecally or intravenously did not have any adverse neurological effects and systemic complications did not occur. The MBP epitope for MS anti-MBP has been localized to an area between Pro85 and Pro96.
Patent NZ-331342-A (NZ)
Title: Control system for a plurality of groups of lifts with destination call control system
Inventor: FRIEDLI PAUL
IPC: B66B3/00
Filed: 1997-02-18
Abstract: The invention concerns a control system for a plurality of groups of lifts (G1 - G5), according to which system the passenger can input his destination at any destination call input device (TE) without having to know which group of lifts (G1 - G5) serves the desired storey. In this way, in large buildings in which, for structural reasons, the ranges of storeys served by individual groups of lifts (G1 - G5) are disposed adjacent one another in a confused manner, the passenger's search for the appropriate lift is facilitated. The multiple group control system always selects the most favourable lift from all the available lifts and, when the storey ranges served by a plurality of groups of lifts (G1 - G5) overlap, the selection is made from all the possible lifts. If the passenger has to change lifts, the connecting lift is shown on a display.
Patent NZ-331432-A (NZ)
Title: Process for the preparation of N-methyl-D-phenylalanyl-N-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3 -difluoro-2-oxohexyl]-l-prolinamide
Inventor: RUDISELL DUANE ERIC
IPC: C07K1/06
Filed: 1997-02-25
Abstract: The specification describes a process for preparing the above compound N-methyl-D-phenylalanyl-N-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide or a pharmaceutically acceptable salt therof and to a key intermediate by directly guanylating Dakin-West intermediates.
Patent NZ-331656-A (NZ)
Title: Backwashing of partially processed wool
Inventor: ROBINSON GARY ALFRED
IPC: D01B3/04
Filed: 1997-03-14
Abstract: A process for treating a fibre assembly travelling at 60m/min or greater including: a) subjecting the fibre assembly to a scouring treatment effective to remove contaminants apart from residual contaminants from the fibre assembly b) carding the scoured fibre in a manner resulting in the adhesion of the contaminants being reduced and the residual contaminants being located primarily on the outer surfaces of the fibres in the assembly and; c) backwashing the fibre assembly subsequent to said carding by directing one or more flows of a fluid to dislodge the residual contaminants from the assembly. Also claimed is the apparatus for treating the fibre assembly.
Patent NZ-504201-A (NZ)
Title: 1-keto-3-(2-fur-2-ylethenyl)2-oxodihydroquinoline as an acarcide against ectoparasites, in particular Psoroptes cuniculi (rabbit ear canker mite) and Psoroptes ovis (sheep scab mite)
Inventor: HODGKINSON LESLIE CHARLES
IPC: A01N43/86
Filed: 2000-04-27
Abstract: The use of 1-keto-3-(2-fur-2-ylethenyl)2-oxodihydroquinoline as an acaricide.  The acarids are selected from Psoroptes cuniculi and Psoroptes ovis.
Patent NZ-505755-A (NZ)
Title: Dispensing device for paper towels obtained by manual cutting from a continuous band
Inventor: CASSIA ANTONIA M
IPC: A47K10/36
Filed: 1999-01-12
Abstract: A dispensing device for paper towels cut from a continuous band includes a manually-operated feeding and cutting mechanism provided with at least a pair of blades mounted on a roller and at least a pair of blades fixedly mounted and positioned to interfere with the blades carried by the roller, said pairs of blades being mounted and structured so as to achieve during the cutting a punctiform contact between a rigid blade and a yielding blade. Preferably, the fixed blades are flexible and converging upwards whereas the rotating blades are rigid and horizontal. The case of the device also includes catches suitable to engage corresponding resilient latching means formed on the mechanism whereby the latter can be easily removed from the device.
Patent NZ-510837-A (NZ)
Title: Safety edge for skis and snowboards where the safety edge has a cross section that varies along its length to form indentations or protrusions
Inventor: STUCKI WALTER
IPC: A63C5/00
Filed: 1999-10-04
Abstract: A safety edge for skis and snowboards (1), which has indents and protruding areas (3', 3'') of variable thickness.  The indents and protruding areas vary in length, width and height depending on the type of ski or snowboard concerned and provide durable support on surfaces such as snow, ice and artificial snow
Patent NZ-517433-A (NZ)
Title: Control rod
Inventor: DANKOW MARK W
IPC: F16C7/02
Filed: 2000-09-01
Abstract: A  fabricated control rod is disclosed having a spacer with  a  "C" or "U-shaped" channel cross-section. The spacer also  has  a  bushing tube welded to each of its ends.  Each end  of  the  spacer  is  shaped  to  have  a  substantially continuous mating engagement with the exterior side  surface of   the   adjacent   bushing  tube.  Also,   at   least   a substantially  complete  perimeter  weld  joins   both   the interior  and  exterior of each shaped end  to  the  bushing tube.
Patent NZ-517499-A (NZ)
Title: Proteinic drug delivery system using membrane mimetics
Inventor: MODI PANKAJ
IPC: A61K45/00
Filed: 2000-03-24
Abstract: A mixed liposome pharmaceutical formulation with multilamellar vesicles.  The formulation comprises a proteinic pharmaceutical agent, water, an alkali metal C8 to C22 alkyl sulphate in a concentration of from 1 to 10 wt./wt.% of the total formulation, at least one membrane-mimetic amphiphile and at least one phospholipid. The membrane mimectic is hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, lauramidopropyl betain, lauramide monoisopropanolamide, sodium cocoamphopropionate, bishydroxypropyl dihydroxypropyl stearammonium chloride, polyoxyethylene dihydroxypropyl stearammonium chloride, dioctadecyldimethylammonium chloride, sulphosuccinates, stearamide DEA, gamma-linoleic acid, borage oil, evening primrose oil, monoolein, sodium tauro dihydro fusidate, fusidic acid, alkali metal isostearyl lactylates, alkaline earth metal isostearyl lactylates, panthenyl triacetate, cocamidopropyl phosphatidyl PG-diammonium chloride, stearamidopropyl phosphatidyl PG-diammonium chloride, borage amidopropyl phosphatidyl PG-diammonium chloride, borage amidopropyl phosphatidylcholine, polysiloxy pyrrolidone linoleyl phospholipid, trihydroxy-oxo-cholanylglycine and alkali metal salts thereof, and octylphenoxypolythoxyethanol, polydecanol X-lauryl ether, polydecanol X-oleyl ether, wherein X is 9 to 20, or combinations thereof. The phospholipid is phospholipid GLA, phosphatidyl serine, phosphatidylethanolamine, inositolphosphatides, dioleoylphosphatidylethanolamine, sphingomyelin, ceramides, cephalin, triolein, lecithin, saturated lecithin and lysolecithin, and combinations thereof. The amount of each membrane mimetic amphiphile and phospholipid is present in a concentration of from 1 to 10 wt./wt.% of the total formulation, and the total concentration of membrane mimetic amphiphiles and phospholipids is less than 50 wt./wt.% of the formulation. Also described is a pressurised container containing a propellant that is liquid under pressure, the formulation described above, and a phenolic compound selected from phenol and methyl phenol in a concentration of from 1 to 10 wt./wt.% of the formulation. Also described is the use of the pharmaceutical agent for the administration of an aerosol pharmaceutical formulation by spraying a predetermined amount of a mixture of propellant (particularly into the buccal cavity of a human) and an intermediate formulation which comprises the formulation described above and a phenolic compound selected from phenol and methyl phenol in a concentration of from 1 to 10 wt./wt.% of the formulation.
Patent NZ-517744-A (NZ)
Title: Method for enhanced supercooling of plants to provide frost protection
Inventor: GLENN DAVID MICHAEL
IPC: A01N25/26
Filed: 2000-09-12
Abstract: A method for enhancing supercooling of a plant to temperatures below about -2 degrees celcius, involving preventing the formation of ice crystals adjacent to the plant by forming a substantially continuous hydrophobic membrane of particulate materials on portions of the plant capable of supporting droplets of water. The particulate material has a particle size distribution at least about 90 % by weight of the particles have a particle size of about 100 micrometres or less. The substantially continuous hydrophobic membrane has a thickness from about 1 micrometre to about 1,000 micrometres. The particulate material comprises a hydrophilic core comprising at least one of calcium carbonate, mica, talc, kaolin, bentonite, pyrophyllite, dolomite, silica, feldspar, sand, quartz, chalk, limestone, diatomaceous earth, baryte, aluminium trihydrate and titanium dioxide.
Patent NZ-519521-A (NZ)
Title: Sensitive substance encapsulation
Inventor: PACIFICO CARL J
IPC: A23L1/00
Filed: 2000-12-13
Abstract: A method of encapsulating a sensitive material comprising: plating the sensitive material onto a solid carrier, in an atmosphere inert to the sensitive material, to form a plated material; and encapsulating the plated material; wherein the sensitive material is a temperature/oxygen sensitive material or a volatile material.
Patent NZ-520344-A (NZ)
Title: Process for the protection of reinforcement in reinforced concrete
Inventor: GLASS GARETH KEVIN
IPC: C23F13/02
Filed: 2001-01-26
Abstract: A process for reducing the corrosion of steel in reinforced concrete which process comprises forming a deposit of solid alkali on the steel by passing a direct electric current between an anode and the reinforcement as cathode before the concrete has hardened.
Patent NZ-524190-A (NZ)
Title: Melanocortin receptor ligands
Inventor: EBETINO FRANK HALLOCK
IPC: C07K5/08
Filed: 2001-09-26
Abstract: Disclosed are compounds of formula (I), wherein Ar is an aryl or heteroaryl ring selected from the group consisting of phenyl, thiphene, furan, oxazole, thiazole, pyrrole and pyridine, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of a disorders elected from insulin resistance, glucose intolerance, Type-2 diabetes mellitus, coronary artery disease, elevated blood pressure, hypertension, dyslipidaemia, cancer, menstrual irregularities, hirsutism, infertility, gallbladder disease, restrictive lung disease, sleep apnea, gout, osteoarthritis, and thromboelic disease.
Patent NZ-526415-A (NZ)
Title: Process for producing dried singulated cellulose pulp fibers using a jet drier and injected steam and the product resulting therefrom
Inventor: YANCEY MICHAEL JAMES
IPC: F26B20/00
Filed: 2003-06-11
Abstract: A process for the production of singulated pulp fibers, whereby introducing wet pulp (44), steam (94), and air (94) into a jet drier (20). The drying of the pulp utilising the jet drier forms singulated pulp fibers. These singulated pulp fibers are then removed from the jet drier and the pulp fibers separated from the air. The system consists of a jet drier (20), a pulp supply station (40), an air supply (90), an outlet flow conduit (30), and fiber separation station (100).
Patent NZ-532525-A (NZ)
Title: Combination therapy comprising ZD6474 and a taxane used in cancer treatment
Inventor: WEDGE STEPHEN ROBERT
IPC: A61K31/337
Filed: 2002-11-06
Abstract: Use of ZD6474 or a pharmaceutically acceptable salt thereof and a taxane selected from paclitaxel and docetaxel in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human, particularly for the treatment of a cancer involving a solid tumour, wherein the human is optionally being treated with ionising radiation.
Patent NZ-536557-A (NZ)
Title: A pharmaceutical composition comprising a combination of valsartan, amlodipine and hydrochlorothiazide
Inventor: SHETTY SURAJ SHIVAPPA
IPC: A61K31/196
Filed: 2003-05-16
Abstract: A pharmaceutical composition comprising a combination of active ingredients consisting of valsartan, amlodipine and hydrochlorothiaxide for the treatment of a cardiovascular disorder or hypertension.
Patent NZ-537792-A (NZ)
Title: A lock having a cylinder attached in a particular manner
Inventor: CONSTANTINOU JOHN
IPC: E05C1/08
Filed: 2005-01-19
Abstract: A lock has a locking block which can move between a locking position and a unlocking position, a cylinder cam that causes the locking block to move between its said positions, a cylinder cam stop member that limits the degree of rotation of the cylinder cam, the cylinder cam stop member being movable between a stop position where the degree of rotation of the cylinder cam is limited, and a free position where the cylinder cam can rotate further, and locking means to lock the cylinder cam stop member into the stop position. Thus, as the reason for unlocking the stop member would typically be to remove the cylinder (containing the cylinder cam) from the lock, it is efficient to make the locking means "dual purpose" by having the locking means locking the cylinder in the lock as well as locking the stop member in place.
Patent NZ-540493-A (NZ)
Title: Uses of adenosine A2a receptor antagonists
Inventor: GRZELAK MICHAEL
IPC: A61K45/06
Filed: 2003-12-17
Abstract: Disclosed is the use of adenosine A2a receptor antagonists having the structural formula (I) in the treatment of Extra-pyramidal Syndrome in a patient treated with an antipsychotic agent.
Patent NZ-540596-A (NZ)
Title: Process for operating a water recovery plant in a manufacturing or construction facility wherein water contaminated with solids is processed and re-used
Inventor: PANUCCIO MARIO
IPC: C02F1/00
Filed: 2003-12-10
Abstract: A process for operating a water recovery plant comprising charging a storage tank with water contaminated with solids, said water recovered from a manufacturing or construction process, determining a parameter associated with the concentration of one or more selected contaminants in the storage tank, diluting the water contaminated with solids whereby the concentration of the one or more selected contaminants in the storage tank is at or below a desired level, and utilising water from the storage tank in the manufacturing process.
Patent NZ-545642-A (NZ)
Title: Container for food products
Inventor: KNEBL LASZLO
Filed: 2006-03-01
Abstract: A container is disclosed for use in forming a sealed package (10) having a base (32), a first end wall (16), and two converging side walls (12, 14) which either meet at an end, or join a second wall which is shorter than the first wall. The container may contain a food product which is typically provided as a series of discrete pieces or units. The sides of the container define interlocking means, in the form of cylindrical depending lugs (34) and the mating lugs or apertures (36), such that a plurality of such containers can be attached or interlocked to one another along their sides, to form an assembly of such containers. The container contains product and is sealed with a peel off film or foil.
Patent NZ-545880-A (NZ)
Title: A method for dispersing metal oxides
Inventor: LYNCH MAURICE GERARD
IPC: A23L5/41
Filed: 2004-09-20
Abstract: A method for preparing a stable dispersion of a metal oxide in water comprising dispersing colloidal microcrystalline cellulose in water either prior to or concurrently with adding said metal oxide and recovering said stable metal oxide dispersion, wherein: (i) said metal oxide has an average particle size of less than 250 nanometers, (ii) said metal oxide is not iron oxide, (iii) said colloidal microcrystalline cellulose is coprocessed with a polymeric binder and (iv) said metal oxide is present in an amount of at least 0.6% by weight of the total weight of the dispersion. Also disclosed are dispersion compositions made by the above methods and their use as cosmetics, sunscreens, pharmaceuticals, paints, coatings, textiles or food products.
Patent NZ-546337-A (NZ)
Title: Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
Inventor: DOKEN KAZUHIRO
IPC: A61K31/4439
Filed: 2004-10-21
Abstract: A solid preparation useful as a diabetes-treating agent or the like and excellent in the dissolution properties of an insulin sensitizer and an insulin secretagogue, which comprises an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester is provided. Particularly disclosed is a solid preparation comprising pioglitazone or its salt, glimepiride and Polysorbate 80.
Patent NZ-547110-A (NZ)
Title: A sill trolley for a bi-fold door assembly
Inventor: LLOYD ROSS
Filed: 2005-01-28
Abstract: A sill trolley for carrying two hinged together door panels of a bi-fold door assembly having a sill that extends under door panels from one side of the assembly to the other, the sill having an upper surface over an elongate sill cavity that extends in a direction along the length of the sill and defines internal track surfaces for said trolley within the cavity. The sill trolley is mountable within the cavity, and has sill track weight bearing surfaces for engaging with internal track surfaces of the cavity to guide the trolley for movement along the track. The sill trolley has an upstanding connector that, in use, extends above the upper surface of the sill and provides holding connection with a hinge pin of the two hinged together door panels. The connector positions the hinge pin offset relative to the central longitudinal axis of the sill trolley, whereby the weight of the two door panels is carried by the sill trolley by the weight bearing surfaces thereof wholly on said tracks and within the cavity and below said upper surface. The sill trolley acts to support and guide the door panels along the track as they are opened and closed whilst maintaining holding of said hinge pin laterally offset relative to the central longitudinal axis of said sill trolley.
Patent NZ-547772-A (NZ)
Title: 19-nor-D-homosteroids having a mixed androgenic and progestagenic profile
Inventor: VAN DER LOUW JAAP
IPC: C07J63/00
Filed: 2004-12-15
Abstract: Disclosed are 19-nor-D-homosteroids that have a mixed androgenic and progestagenic profile, are orally active, prevent trabecular bone mineral density (BMD) loss, and which lack liver toxicity. The steroids have a structure according to the formula (I) wherein, R1 is O, or NOR, with R being hydrogen, (Cl-6)alkyl or (Cl-6)acyl, R2 is methyl or ethyl, and R3 is hydrogen or (C1-15)acyl.
Patent NZ-548412-A (NZ)
Title: Screen Insert
Inventor: UPFIELD ANTONY WILLIAM
Filed: 2006-07-10
Abstract: A screen insert 150, for securing a rigid or semi-rigid screen mesh in a frame of a security screen, is adapted to enclose an edge 154 of a screen mesh 152. The insert 150 has a double chamber cavity 156 designed to receive a folded back portion 158 of the edge of the screen mesh 152 therein. When the insert 150 is received in a frame recess, withdrawal of the screen mesh 152 is inhibited by the folded back portion 158 which is held captive within a chamber of the double cavity 156. The insert 150 is also provided with a series of barb-shaped ribs 168 extending along the outer surfaces of the side wall portions of the insert. These barb-shaped ribs 168 are designed to engage with the inner surfaces of the frame recess and help to retain the insert 150 in the frame recess in use.
Patent NZ-552462-A (NZ)
Title: Method for controlling the microbiological quality of an aqueous medium and kit therefor
Inventor: RENAUD PATRICIA
IPC: C12Q1/6893
Filed: 2001-07-06
Abstract: Disclosed is a method for establishing the microbiological quality of an aqueous environmental medium, liable to comprise various microorganisms, comprising the steps of: providing a sample to be tested and a reference set, consisting of at least a bacterium, a parasite and a virus, representative, together or separately of a level of microbiological quality; utilising a kit for microbiological determination is available, consisting of at least one identifying probe specific for a bacterium, said identifying probe being chosen from SEQ ID NO:1 to SEQ ID NO:39, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:66 to SEQ ID NO: 69 and any fragments thereof comprising at least 5 contiguous monomers included in any one of said sequences, and having a sequence exhibiting at least 70% identity with said any sequence; at least one identifying probe specific for a parasite said identifying probe being chosen from SEQ ID NO: 40 to SEQ ID NO:49, SEQID NO:63 to SEQ ID NO:65 and any fragments thereof comprising at least 5 contiguous monomers included in any one of said sequences, and having a sequence exhibiting at least 70% identity with said any sequence; and at least one identifying probe specific for a virus, said identifying probe being chosen from SEQ ID NO:50 to SEQ ID NO:60, SEQ ID NO:70, SEQ ID NO:104 and any fragments thereof comprising at least 5 contiguous monomers included in any one of said sequences, and having a sequence exhibiting at least 70% identity with said any sequence; wherein the sample and the reference set, or any fraction obtained from the latter, are brought into contact with said determination kit as a result of which, any microorganisms are detected, wherein this determination is representative of the level of microbiological quality of the medium.
Patent NZ-562130-A (NZ)
Title: Optical phase conjugation laser diode with retro-reflecting elements
Inventor: HENRICHS JOSEPH REID
IPC: H01S3/13
Filed: 2006-03-07
Abstract: Disclosed is an optical phase conjugating laser diode. The diode includes a first reflector (168), a second reflector (165), and a gain-medium (160, 161, 162) sandwiched between the first and second reflectors. The second reflector is used to provide for a partial reflection and laser-emission output, and the gain medium is used to provide for a stimulated-emission and amplification. The first reflector comprises a phase-conjugating array, the array comprising a plurality of retro-reflecting elements. The first reflector is used to provide for an optical phase conjugation.